Longleaf Partners Fund's third-quarter 2025 investor letter discusses its flat performance, focusing on investments in real assets and brands. Highlighted stock Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) saw positive growth and share repurchases.